Award honors the integration of genomics into
critical illness coverage, enhancing the value of life and critical
illness products for insurers and policyholders.
HUNTSVILLE, Ala., Dec. 10,
2024 /PRNewswire/ -- healthŌme®, Inc., a
leader in genomics-based precision health management, in
partnership with Hannover Re, one of the world's top
reinsurers, has been awarded the prestigious 2024 Global
Innovation Award in the Life | Health | Retirement category.
Presented by the International Insurance Society (IIS),
Insurance Thought Leadership (ITL), and Lloyd's, the
award celebrates organizations driving transformative solutions to
critical insurance and risk management challenges.
"Receiving the 2024 Global Innovation Award is a testament to
healthŌme's dedication to advancing personalized, genomics-driven
healthcare," said Darren Rowe, CEO
of healthŌme. "The support from Hannover Re, our reinsurer, and
Chubb, our exclusive distribution partner in the worksite, has been
vital in providing solutions that prioritize a proactive approach
to health-first insurance-based programs that reshape how the
industry serves members."
This award acknowledges the notable impact of healthŌme's
precision health management program. With support from Hannover Re,
healthŌme successfully integrated genomics-based services into
critical illness and life insurance, delivering an innovative
solution to the personal insurance market. This collaboration
demonstrates how healthŌme and Hannover Re empower insurers to push
boundaries, improve product offerings, and enhance member
engagement. By providing groundbreaking living benefit solutions,
they also strengthen policyholder relationships, improve brand
equity for insurance carriers, and drive better policy persistency,
creating lasting value for insurers and their customers.
"We're thrilled to receive this prestigious award, in
collaboration with our partner healthŌme, that recognizes our
commitment to advancing medical care for the treatment of cancer
patients," said Steve Najjar,
Executive Vice President, Head of Health Solutions and General
Counsel at Hannover Life Reassurance Company of America. "This
partnership allows us to leverage genomic-based technologies and
life insurance solutions to enhance patient care and support
individuals in living longer, healthier lives."
In partnership with Chubb, healthŌme's innovative services are
distributed through Chubb Workplace Benefits as Cancer
Advocate Plus. healthŌme provides employees access to
proactive, DNA-based precision health insights, a personalized
medication optimization plan, and tailored cancer management
support. Pairing these services provided by healthŌme with the
insurance benefits offered by Chubb, Cancer Advocate Plus is
redefining insurance with health-first solutions.
"This benefits partnership exemplifies our focus on innovating
and delivering value for our customers," said Alex Faynberg, Division President, Chubb
Workplace Benefits. "It's a proactive and personalized approach to
combining precision health insights with cancer management support.
And we are honored to offer this program to our broker partners and
clients."
The recognition by the IIS underscores the significant strides
made by healthŌme and its partners in integrating advanced genomics
into insurance products, delivering enhanced value, and enabling
personalized care for policyholders. In 2025, the product will also
be available for individuals to purchase outside the workplace as
Kadance Precision Health Management Program, further expanding
access to precision health and highlighting a shared commitment to
driving innovation and excellence in insurance and healthcare.
About healthŌme, Inc.
healthŌme, Inc. is a
genomics-based, precision health navigation company operating at
the intersection of life insurance, life science, and health
management. With a fully integrated, in-house genetics lab,
healthŌme is dedicated to simplifying and accelerating access to
technologies and services that can dramatically alter an
individual's health trajectory, with an initial focus on cancer.
healthŌme designs and delivers tech-enabled, precision health
management solutions through a network of life and critical
insurance carriers. healthŌme and its subsidiary, Kailos Genetics,
are based at the HudsonAlpha Institute for Biotechnology in
Huntsville, Alabama. To learn
more, visit www.healthome.com and stay connected on
LinkedIn.
About Hannover Re
Hannover Re is one of the
world's leading reinsurers. It transacts all lines of property and
casualty and life and health reinsurance and is present worldwide
with more than 3,500 staff. German business of the Hannover Re
Group is written by the subsidiary E+S Rück. Established in 1966,
Hannover Re is recognized as a reliable partner for innovative risk
solutions, exceptional customer intimacy and financial soundness.
The rating agencies most relevant to the insurance industry have
awarded both Hannover Re and E+S Rück outstanding financial
strength ratings: Standard & Poor's AA- "Very Strong" and A.M.
Best A+ "Superior".
About Chubb
Chubb is a world leader in insurance. With
operations in 54 countries and territories, Chubb provides
commercial and personal property and casualty insurance, personal
accident and supplemental health insurance, reinsurance and life
insurance to a diverse group of clients. The company is defined by
its extensive product and service offerings, broad distribution
capabilities, exceptional financial strength and local operations
globally. Parent company Chubb Limited is listed on the New York
Stock Exchange (NYSE: CB) and is a component of the S&P 500
index. Chubb employs approximately 40,000 people worldwide.
Additional information can be found at: www.chubb.com.
View original
content:https://www.prnewswire.com/news-releases/healthme-and-hannover-re-win-2024-global-innovation-award-for-genomics-based-insurance-program-302326945.html
SOURCE healthŌme, Inc.